Total Knee Replacement as a Knee Osteoarthritis Outcome: Predictors Derived from a 4-Year Long-Term Observation following a Randomized Clinical Trial Using Chondroitin Sulfate

Cartilage

Volumn 4, Issue 3, 2013, Pages 219-226

  Raynauld, Jean Pierre ^a   Martel Pelletier, Johanne ^a   Dorais, Marc ^b   Haraoui, Boulos ^a   Choquette, Denis ^a   Abram, François ^c   Beaulieu, André ^d   Bessette, Louis ^e   Morin, Frédéric ^f   Wildi, Lukas M ^a   Pelletier, Jean Pierre ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b StatSciences Inc   (Canada)

^c INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e Groupe de Recherche en Rhumatologie et Maladies Osseuses   (Canada)

^f Centre de Recherche Musculo squelettique   (Canada)

Author keywords

chondroitin sulfate; knee osteoarthritis; knee replacement; MRI

Indexed keywords

C REACTIVE PROTEIN; CHONDROITIN SULFATE; CONDROSAN; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTENTION TO TREAT ANALYSIS; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; TELECONSULTATION; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

EID: 84879141778     PISSN: 19476035     EISSN: 19476043     Source Type: Journal    
DOI: 10.1177/1947603513483547     Document Type: Article

References (28)

1. Reginster JY,Deroisy R,Rovati LC,Lee RL,Lejeune E,Bruyere O, et al.Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.Lancet. 2001;357:251-6.
2. Michel BA,Stucki G,Frey D,De Vathaire F,Vignon E,Bruehlmann P, et al.Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial.Arthritis Rheum. 2005;52:779-86.
3. Kahan A,Uebelhart D,De Vathaire F,Delmas PD,Reginster JY.Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial.Arthritis Rheum. 2009;60:524-33.
4. Peterfy CG,van Dijke CF,Janzen DL,Gluer CC,Namba R,Majumdar S, et al.Quantification of articular cartilage in the knee with pulsed saturation transfer subtraction and fat- suppressed MR imaging: optimization and validation.Radiology. 1994;192:485-91.
5. Felson DT,McLaughlin S,Goggins J,LaValley MP,Gale ME,Totterman S, et al.Bone marrow edema and its relation to progression of knee osteoarthritis.Ann Intern Med. 2003;139:330-6.
6. Raynauld JP,Martel-Pelletier J,Berthiaume MJ,Labonté F,Beaudoin G,de Guise JA, et al.Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes.Arthritis Rheum. 2004;50:476-87.
7. Berthiaume MJ,Raynauld JP,Martel-Pelletier J,Labonté F,Beaudoin G,Bloch DA, et al.Meniscal tear and extrusion are strongly associated with the progression of knee osteoarthritis as assessed by quantitative magnetic resonance imaging.Ann Rheum Dis. 2005;64:556-63.
8. Eckstein F,Cicuttini F,Raynauld JP,Waterton JC,Peterfy C.Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessment.Osteoarthritis Cartilage. 2006;14:A46-75.
9. Hunter DJ,Zhang Y,Niu J,Goggins J,Amin S,LaValley MP, et al.Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis.Arthritis Rheum. 2006;54:1529-35.
10. Felson DT,Niu J,Guermazi A,Roemer F,Aliabadi P,Clancy M, et al.Correlation of the development of knee pain with enlarging bone marrow lesions on magnetic resonance imaging.Arthritis Rheum. 2007;56:2986-92.
11. Raynauld JP,Martel-Pelletier J,Berthiaume MJ,Abram F,Choquette D,Haraoui B, et al.Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period.Ann Rheum Dis. 2008;67:683-8.
12. Pelletier JP,Raynauld JP,Caron J,Mineau F,Abram F,Dorais M, et al.Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis.Ann Rheum Dis. 2010;69:2095-101.
13. Wildi LM,Raynauld JP,Martel-Pelletier J,Beaulieu A,Bessette L,Morin F, et al.Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI.Ann Rheum Dis. 2011;70:982-9.
14. Raynauld JP,Martel-Pelletier J,Bias P,Laufer S,Haraoui B,Choquette D, et al.Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI.Ann Rheum Dis. 2009;68:938-47.
15. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for the Industry.Clinical Development Programs for Drugs, Devices and Biological Products Intended for the Treatment Osteoarthritis. 1999;:.
16. Committee for Medicinal Products for Human Use (CHMP). Guideline on Clinical Investigation of Medicinal Products Used in the Treatment of Osteoarthritis (CPMP/EWP/784/97 Rev 1). London: European Medicines Agency; January 2010.
17. Altman RD,Abadie E,Avouac B,Bouvenot G,Branco J,Bruyere O, et al.Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis.Osteoarthritis Cartilage. 2005;13:13-9.
18. Wang Y,Simpson JA,Wluka AE,Teichtahl AJ,English DR,Giles GG, et al.Relationship between body adiposity measures and risk of primary knee and hip replacement for osteoarthritis: a prospective cohort study.Arthritis Res Ther. 2009;11:R31.
19. Wang Y,Simpson JA,Wluka AE,Urquhart DM,English DR,Giles GG, et al.Reduced rates of primary joint replacement for osteoarthritis in Italian and Greek migrants to Australia: the Melbourne Collaborative Cohort Study.Arthritis Res Ther. 2009;11:R86.
20. Tanamas SK,Wluka AE,Pelletier JP,Martel-Pelletier J,Abram F,Wang Y, et al.The association between subchondral bone cysts and tibial cartilage volume and risk of joint replacement in people with knee osteoarthritis: a longitudinal study.Arthritis Res Ther. 2010;12:R58.
21. Tanamas SK,Wluka AE,Pelletier J-P,Pelletier J,Abram F,Berry PA, et al.Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study.Rheumatology (Oxford). 2010;49:2413-9.
22. Cicuttini FM,Jones G,Forbes A,Wluka AE.Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study.Ann Rheum Dis. 2004;63:1124-7.
23. Bruyere O,Pavelka K,Rovati LC,Gatterova J,Giacovelli G,Olejarova M, et al.Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials.Osteoarthritis Cartilage. 2008;16:254-60.
24. Bellamy N,Buchanan WW,Goldsmith CH,Campbell J,Stitt LW.Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.J Rheumatol. 1988;15:1833-40.
25. Raynauld JP,Martel-Pelletier J,Haraoui B,Choquette D,Dorais M,Wildi LM, et al.Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation.Ann Rheum Dis. 2011;70:1382-8.
26. Wluka AE,Wolfe R,Stuckey S,Cicuttini FM.How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis?.Ann Rheum Dis. 2004;63:264-8.
27. Raynauld JP,Martel-Pelletier J,Berthiaume MJ,Beaudoin G,Choquette D,Haraoui B, et al.Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes.Arthritis Res Ther. 2006;8:R21.
28. Javaid MK,Kiran A,Guermazi A,Kwoh CK,Zaim S,Carbone L, et al.Individual magnetic resonance imaging and radiographic features of knee osteoarthritis in subjects with unilateral knee pain: the health, aging, and body composition study.Arthritis Rheum. 2012;64:3246-55.